BNC210 for adults with PTSD: a placebo-controlled study
About this title
A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)
Read the official source — NCT04951076Researchers compared BNC210 and placebo to find out how the approaches affected post-traumatic stress symptoms in adults with PTSD.
Understand this study
What did researchers investigate?
Researchers compared BNC210 and placebo to find out how the approaches affected post-traumatic stress symptoms in adults with PTSD.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
- Listed locations
- Bellflower and 31 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 212
- Sponsor
- Bionomics Limited
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, United Kingdom
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT04951076
- Official title
Show the full official title
A Phase 2b, Randomized, Double Blind, Two Arm Study to Investigate the Effects of BNC210 Tablet Formulation Compared to Placebo in Adults With Post-Traumatic Stress Disorder (PTSD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
Bellflower, United States · Beverly Hills, United States · Colton, United States
29 more locations
- Oceanside, United States
- Orange, United States
- Temecula, United States
- Jacksonville, United States
- Lauderhill, United States
- Miami Lakes, United States
- Orlando, United States
- Overland Park, United States
- Prairie Village, United States
- New Bedford, United States
- Las Vegas, United States
- Berlin, United States
- Cherry Hill, United States
- Cedarhurst, United States
- Staten Island, United States
- North Canton, United States
- Oklahoma City, United States
- West Chester, United States
- Memphis, United States
- Austin, United States
- Dallas, United States
- Draper, United States
- Barnsley, United Kingdom
- Blackpool, United Kingdom
- Cannock, United Kingdom
- Leeds, United Kingdom
- Liverpool, United Kingdom
- Manchester, United Kingdom
- Stockton-on-Tees, United Kingdom
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers compared BNC210 and placebo to find out how the approaches affected post-traumatic stress symptoms in adults with PTSD.
Who is behind this study?
The study sponsor is Bionomics Limited.
Did this study involve medication?
Yes. The study involved medication, including BNC210 and Placebo.
Who was this study for?
This study was for people with PTSD. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.
